Cargando…
Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine
IMPORTANCE: No data comparing the estimated effectiveness of coadministering COVID-19 vaccines with seasonal influenza vaccine (SIV) in the community setting exist. OBJECTIVE: To examine the comparative effectiveness associated with coadministering the BNT162b2 BA.4/5 bivalent mRNA COVID-19 vaccine...
Autores principales: | McGrath, Leah J., Malhotra, Deepa, Miles, Amanda C., Welch, Verna L., Di Fusco, Manuela, Surinach, Andy, Barthel, Andrea, Alfred, Tamuno, Jodar, Luis, McLaughlin, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632958/ https://www.ncbi.nlm.nih.gov/pubmed/37938846 http://dx.doi.org/10.1001/jamanetworkopen.2023.42151 |
Ejemplares similares
-
BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5
por: Tartof, Sara Y, et al.
Publicado: (2022) -
Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants
por: Tartof, Sara Y, et al.
Publicado: (2022) -
906. Risk of Shingles among Patients Aged 45–49 versus 50–54 Years in the US, by Immune Status
por: Miles, Amanda C, et al.
Publicado: (2023) -
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study
por: Tartof, Sara Y, et al.
Publicado: (2023) -
Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age
por: Khan, Farid L., et al.
Publicado: (2022)